ici 164384 has been researched along with promegestone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chetrite, G; Nguyen, BL; Pasqualini, JR | 1 |
Conover, CA; Harris, SA; Kassem, M; Okazaki, R; Riggs, BL; Spelsberg, TC | 1 |
2 other study(ies) available for ici 164384 and promegestone
Article | Year |
---|---|
Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).
Topics: 17-Hydroxysteroid Dehydrogenases; Biotransformation; Breast Neoplasms; Danazol; Estradiol; Estrogen Antagonists; Estrone; Humans; Neoplasms, Hormone-Dependent; Polyunsaturated Alkamides; Promegestone; Tumor Cells, Cultured | 1995 |
Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor.
Topics: Bucladesine; Cell Line; Colforsin; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Osteoblasts; Polymerase Chain Reaction; Polyunsaturated Alkamides; Progesterone Congeners; Promegestone; Receptors, Estrogen; RNA, Messenger; Sensitivity and Specificity; Time Factors; Up-Regulation | 1998 |